ISSN: 1871-529X
Journal Home
Journal Guideline
Cardiovascular and Hematological Disorders - Drug Targets Q3 Unclaimed
Cardiovascular and Hematological Disorders - Drug Targets is a journal indexed in SJR in Medicine (miscellaneous) and Pharmacology with an H index of 46. It has an SJR impact factor of 0,235 and it has a best quartile of Q3. It has an SJR impact factor of 0,235.
Type: Journal
Type of Copyright:
Languages:
Open Access Policy:
Type of publications:
Publication frecuency: -
- €
Inmediate OANPD
Embargoed OA- €
Non OAMetrics
0,235
SJR Impact factor46
H Index25
Total Docs (Last Year)98
Total Docs (3 years)1354
Total Refs99
Total Cites (3 years)93
Citable Docs (3 years)0.97
Cites/Doc (2 years)54.16
Ref/DocOther journals with similar parameters
Canadian Respiratory Journal Q3
Current Stem Cell Research and Therapy Q3
Polish Journal of Microbiology Q3
JMIR Research Protocols Q3
Deutsches AÃàrzteblatt international Q3
Compare this journals
Aims and Scope
Best articles by citations
Orthostatic Hypotension: Evaluation and Treatment
View moreAnticoagulant Therapy in Very Old Patients
View moreCo-existence of follicular lymphoma in the lymph node with High-grade B cell lymphoma in the bone marrow of a patient presenting with spontaneous tumor lysis syndrome
View moreMyocardial Ischemia/Reperfusion Injury: Potential of TRPV1 Agonists as Cardioprotective Agents
View moreDiagnostic Value of HLA Typing in Pathogenesis of Cardiomyopathy
View moreCardiovascular Disease Burden and Risk Factors Before and After Kidney Transplant
View moreEDITORIAL (Thematic Issue: Novel Oral Anticoagulation-A Milestone in Anticoagulation History)
View moreGlucose lowering activity of aqueous Ammodaucus leucotrichus extract in diabetic rats
View moreA Stress Repair Mechanism That Maintains Vertebrate Structure During Stress
View moreHiv-Related Lymphoprolipherative Diseases In The Era Of Combination Antiretroviral Therapy.
View morePrevention of Sudden Cardiac Death in Hemodialysis Patients
View moreRho-Signaling Pathways in Chronic Myelogenous Leukemia
View moreMeet Our Editorial Board Member
View moreThe Use of Novel Oral Anticoagulants in Atrial Fibrillation
View morePharmacologic Targeting of Endothelial Progenitor Cells
View morePediatric CKD and Cardivascular Disease
View moreEditorial (Thematic Issue:Drug-eluting Stents and Concomitant Treatment)
View moreEffect of a Hybrid Peptide Derived from Platelet Type I and Type III Collagen Receptors on CHO-65 Cells
View moreThe Metabolic Syndrome and Vascular Disease in Asia
View moreAuthor Index To Volume 6
View moreCardiovascular Effects of Antiretroviral Drugs: Clinical Review
View moreClopidogrel-Proton Pump Inhibitor Interaction: A Primer for Clinicians
View moreCarfilzomib: A Tale of a Heartbreaking Moment: Case Report and Concise Review of the Literature
View moreDiscussion on Pharmacogenetic Interaction in G6PD Deficiency and Methods to Identify Potential Hemolytic Drugs
View more
Comments